NYSE:EBS   Emergent Biosolutions, Inc.
Added some levels for EBS after 20% up side

EBS got news on approval on nasal product
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.